Monday, February 21, 2011

Antibody To Evaluate Prostate Cancer: HJF Signs Distribution Agreement

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) has signed a licensing agreement with Biocare Medical, a biotechnology company based in Concord, Calif., for the exclusive worldwide sales and distribution rights for the immunohistochemistry of an antibody designed to detect tumor prevalence in prostate cancer patients...


Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/WHxnDTyxLTo/3Rpd

body lean

No comments:

Post a Comment